Oculis Holding AG (OCS) Cash & Current Investments (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Cash & Current Investments came in at $283.5 million in Q1 2026, up 40.12% year-on-year from $202.3 million in Q1 2025, and up 6.39% quarter-over-quarter from $266.5 million in Q4 2025.

Oculis Holding AG (OCS) Cash & Current Investments (2021 - 2026) Analysis & Trends

Oculis Holding AG's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $283.5 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 40.12% year-over-year to $283.5 million in Q1 2026; TTM through Mar 2026 was $283.5 million, a 40.12% increase from a year earlier, with the FY2025 full-year figure at $256.9 million, up 129.09% from the prior year.
  • Cash & Current Investments climbed to $283.5 million in Q1 2026 per OCS's latest filing, from $266.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $283.5 million in Q1 2026 and bottomed at -$51.1 million in Q3 2023.
  • The 5-year median for Cash & Current Investments is $121.7 million (2024), against an average of $115.5 million.
  • Across the five-year window, Cash & Current Investments tumbled 186.92% in 2023 and jumped 730.86% in 2024, its largest moves.
  • Year by year, Cash & Current Investments stood at $20.5 million in 2022, then sank by 186.92% to -$17.9 million in 2023, then soared by 730.86% to $112.6 million in 2024, then surged by 136.64% to $266.5 million in 2025, then grew by 6.39% to $283.5 million in 2026.
  • Per Business Quant, the three latest OCS Cash & Current Investments figures stand at $283.5 million (Q1 2026), $266.5 million (Q4 2025), and $181.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn 3.01 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 283.54 Mn
Dec 31, 2025 266.52 Mn
Sep 30, 2025 181.49 Mn
Jun 30, 2025 193.62 Mn
Mar 31, 2025 202.35 Mn
Dec 31, 2024 112.63 Mn
Sep 30, 2024 121.74 Mn
Jun 30, 2024 130.40 Mn
Mar 31, 2024 91.58 Mn
Dec 31, 2023 -17.85 Mn
Sep 30, 2023 -51.11 Mn
Jun 30, 2023 -33.53 Mn
Dec 31, 2022 20.54 Mn
Dec 31, 2021 50.19 Mn